Skip to main content Accessibility help
×
Home

Quercetin supplementation and its effect on human monocyte gene expression profiles in vivo

  • Inka Boomgaarden (a1), Sarah Egert (a2), Gerald Rimbach (a3), Siegfried Wolffram (a4), Manfred J. Müller (a2) and Frank Döring (a1)...

Abstract

Quercetin has been described as having a wide range of beneficial effects in humans, ranging from anti-carcinogenic properties to reducing the risk of CVD. Nevertheless, underlying molecular mechanisms have been mostly investigated in vitro. Here, we tested whether a daily supplementation of quercetin leads to reproducible changes in human monocyte gene expression profiles. In study I, quercetin in varying dosages was given to healthy subjects for 2 weeks. RNA from monocytes isolated at the beginning and end of the study from subjects receiving 150 mg quercetin per d was subjected to transcriptome-wide microarray analysis. In study II, a double-blind cross-over study, twenty subjects exhibiting a ‘cardiovascular risk phenotype’ received 150 mg quercetin or placebo daily for 6 weeks each and served as the verification group. Microarray analysis revealed a number of differentially expressed genes. The most significantly represented functional groups were those of the immune system, nucleic acid metabolism, apoptosis and O-glycan biosynthesis. Twenty-four genes were chosen for technical replication and independent verification by quantitative real-time PCR. When comparing placebo and quercetin treatment, four genes showed significantly different expression changes (C1GALT1, O-glycan biosynthesis; GM2A, glycolipid catabolism; HDGF, cell proliferation; SERPINB9, apoptosis). However, these were minimal in respect to magnitude of fold change. In conclusion, although microarray analysis revealed extensive effects of quercetin on gene expression, the employment of a placebo-controlled study design showed no comparable results for twenty-four verification targets. This emphasises the need for stringent designs in nutritional intervention studies with the aim to identify relevant changes in gene expression.

Copyright

Corresponding author

*Corresponding author: Professor Dr Frank Döring, fax +49 431 8805658, email sek@molprev.uni-kiel.de

References

Hide All
1 Hertog, MG, Feskens, EJ, Hollman, PC, et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 10071011.
2 Sampson, L, Rimm, E, Hollman, PC, et al. (2002) Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 102, 14141420.
3 Day, AJ, Mellon, F, Barron, D, et al. (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35, 941952.
4 Arts, IC & Hollman, PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, 317S325S.
5 Williamson, G & Manach, C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S255S.
6 Ames, BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221, 12561264.
7 Halliwell, B (1993) The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23, Suppl. 1, 118126.
8 Houstis, N, Rosen, ED & Lander, ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944948.
9 Formica, JV & Regelson, W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33, 10611080.
10 Kawai, Y, Nishikawa, T, Shiba, Y, et al. (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283, 94249434.
11 Lodi, F, Jimenez, R, Moreno, L, et al. (2009) Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis 204, 3439.
12 Boesch-Saadatmandi, C, Pospissil, RT, Graeser, AC, et al. (2009) Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes – role of quercetin metabolism. Int J Mol Sci 10, 41684177.
13 Murtaza, I, Marra, G, Schlapbach, R, et al. (2006) A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. Biotechnol Appl Biochem 45, 2936.
14 Soundararajan, R, Wishart, AD, Rupasinghe, HP, et al. (2008) Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis. J Biol Chem 283, 22312245.
15 van Erk, MJ, Roepman, P, van der Lende, TR, et al. (2005) Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr 44, 143156.
16 de Boer, VC, van Schothorst, EM, Dihal, AA, et al. (2006) Chronic quercetin exposure affects fatty acid catabolism in rat lung. Cell Mol Life Sci 63, 28472858.
17 Dihal, AA, van der Woude, H, Hendriksen, PJ, et al. (2008) Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics 8, 4561.
18 Boots, AW, Wilms, LC, Swennen, EL, et al. (2008) In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 24, 703710.
19 de Pascual-Teresa, S, Johnston, KL, DuPont, MS, et al. (2004) Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J Nutr 134, 552557.
20 Mutch, DM, Crespy, V, Clough, J, et al. (2006) Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver. Am J Physiol Gastrointest Liver Physiol 291, G63G72.
21 Egert, S, Wolffram, S, Bosy-Westphal, A, et al. (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138, 16151621.
22 Egert, S, Bosy-Westphal, A, Seiberl, J, et al. (2009) Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 102, 10651074.
23 Klapper, M, Dopner, M, Vock, C, et al. (2006) Expression analysis of genes involved in fat assimilation in human monocytes. IUBMB Life 58, 435440.
24 Dennis, G Jr, Sherman, BT, Hosack, DA, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3.
25 Brazma, A, Hingamp, P, Quackenbush, J, et al. (2001) Minimum information about a microarray experiment (MIAME) – toward standards for microarray data. Nat Genet 29, 365371.
26 Schmelzer, C, Lorenz, G, Rimbach, G, et al. (2007) Influence of coenzyme Q10 on release of pro-inflammatory chemokines in the human monocytic cell line THP-1. Biofactors 31, 211217.
27 Tsuchiya, S, Yamabe, M, Yamaguchi, Y, et al. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26, 171176.
28 Livak, KJ & Schmittgen, TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25, 402408.
29 Eady, JJ, Wortley, GM, Wormstone, YM, et al. (2005) Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 22, 402411.
30 Radich, JP, Mao, M, Stepaniants, S, et al. (2004) Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 83, 980988.
31 Whitney, AR, Diehn, M, Popper, SJ, et al. (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100, 18961901.
32 Lyons, PA, Koukoulaki, M, Hatton, A, et al. (2007) Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics 8, 64.
33 Pagmantidis, V, Meplan, C, van Schothorst, EM, et al. (2008) Supplementation of healthy volunteers with nutritionally relevant amounts of selenium increases the expression of lymphocyte protein biosynthesis genes. Am J Clin Nutr 87, 181189.
34 McEver, RP (2002) Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 14, 581586.
35 Sperandio, M (2006) Selectins and glycosyltransferases in leukocyte rolling in vivo. FEBS J 273, 43774389.
36 Sperandio, M, Thatte, A, Foy, D, et al. (2001) Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice. Blood 97, 38123819.
37 Babaev, VR, Chew, JD, Ding, L, et al. (2008) Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. Cell Metab 8, 492501.
38 Ermak, N, Lacour, B, Drueke, TB, et al. (2008) Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes. Atherosclerosis 200, 247256.
39 Stoneman, V, Braganza, D, Figg, N, et al. (2007) Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 100, 884893.

Keywords

Type Description Title
PDF
Supplementary materials

Boomgaarden et al. supplementary material
Boomgaarden et al. supplementary figures and tables

 PDF (255 KB)
255 KB

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed